Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Ishida TC"'
Autor:
Sweis RF; Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, Illinois., Gajate P; Medical Oncology Department, Ramón y Cajal University Hospital, Madrid, Spain., Morales-Barrera R; Department of Medical Oncology, Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain., Lee JL; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea., Necchi A; Vita-Salute San Raffaele University, Milan, Italy.; Department of Medical Oncology, IRCCS San Raffaele Hospital, Milan, Italy., de Braud F; Vita-Salute San Raffaele University, Milan, Italy., Penel N; Department of Medical Oncology, Centre Oscar Lambret, University of Lille, Lille, France., Grünwald V; Departments of Urology and Medical Oncology, Universitätsklinikum Essen, Essen, Germany., Maruzzo M; Oncology 1, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy., Meran J; Department of Internal Medicine, Krankenhaus der Barmherzigen Brüder, Vienna, Austria., Ishida TC; Bayer HealthCare Pharmaceuticals, Whippany, New Jersey., Bao W; Bayer HealthCare Pharmaceuticals, Whippany, New Jersey., Zhou Y; Bayer HealthCare Pharmaceuticals, Cambridge, Massachusetts., Ellinghaus P; Bayer AG, Wuppertal, Germany.; Now with Merck KGaA, Darmstadt, Germany., Rosenberg JE; Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
Publikováno v:
JAMA oncology [JAMA Oncol] 2024 Sep 19. Date of Electronic Publication: 2024 Sep 19.
Autor:
Sternberg CN; Englander Institute for Precision Medicine, Weill Cornell Medicine, Sandra and Edward Meyer Cancer Center, New York, NY., Petrylak DP; Yale Cancer Center, New Haven, CT., Bellmunt J; Beth Israel Deaconess Medical Center and PSMAR-IMIM Lab, Boston, MA.; Harvard Medical School, Boston, MA., Nishiyama H; Department of Urology, University of Tsukuba, Tsukuba, Japan., Necchi A; Vita-Salute San Raffaele University and IRCCS San Raffaele Hospital and Scientific Institute, Milan, Italy., Gurney H; Clinical Trials Unit FMHS, Macquarie University, Sydney, New South Wales, Australia., Lee JL; University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea., van der Heijden MS; Medical Oncology, the Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands., Rosenbaum E; Davidoff Cancer Center, Rabin Medical Center, Petah Tikva, Israel., Penel N; Lille University and Department of Medical Oncology, Centre Oscar Lambret, Lille, France., Pang ST; Division of Urology, Department of Surgery, Linkou Chang Gung Memorial Hospital, Linkou, Taiwan., Li JR; Division of Urology, Department of Surgery, Taichung Veterans General Hospital, Taichung, Taiwan., García Del Muro X; Department of Medical Oncology, University of Barcelona, Idibell Institute of Research, Institut Català d'Oncologia Hospitalet, Barcelona, Spain., Joly F; Clinical Research Department, Centre François Baclesse, Caen, France., Pápai Z; Oncology Department, Medical Centre, Hungarian Defence Forces, Budapest, Hungary., Bao W; Bayer HealthCare Pharmaceuticals, Inc, Whippany, NJ., Ellinghaus P; Bayer AG, Wuppertal, Germany., Lu C; Bayer HealthCare Pharmaceuticals, Inc, Whippany, NJ., Sierecki M; Bayer HealthCare Pharmaceuticals, Inc, Whippany, NJ., Coppieters S; Bayer AG, Diegem, Belgium., Nakajima K; Bayer HealthCare Pharmaceuticals, Inc, Whippany, NJ., Ishida TC; Bayer HealthCare Pharmaceuticals, Inc, Whippany, NJ., Quinn DI; Division of Oncology, Department of Medicine, USC Norris Comprehensive Cancer Center, Los Angeles, CA.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2023 Jan 20; Vol. 41 (3), pp. 629-639. Date of Electronic Publication: 2022 Oct 14.